Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rapid Micro Biosystems (RPID) Free Cash Flow (2020 - 2025)

Rapid Micro Biosystems' Free Cash Flow history spans 6 years, with the latest figure at -$3.3 million for Q4 2025.

  • On a quarterly basis, Free Cash Flow rose 67.24% to -$3.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$31.9 million, a 28.23% increase, with the full-year FY2025 number at -$31.9 million, up 28.23% from a year prior.
  • Free Cash Flow hit -$3.3 million in Q4 2025 for Rapid Micro Biosystems, up from -$9.7 million in the prior quarter.
  • Over the last five years, Free Cash Flow for RPID hit a ceiling of -$3.3 million in Q4 2025 and a floor of -$19.8 million in Q3 2021.
  • Historically, Free Cash Flow has averaged -$12.3 million across 5 years, with a median of -$10.7 million in 2022.
  • Biggest five-year swings in Free Cash Flow: plummeted 173.23% in 2021 and later skyrocketed 67.24% in 2025.
  • Tracing RPID's Free Cash Flow over 5 years: stood at -$14.9 million in 2021, then fell by 23.77% to -$18.4 million in 2022, then skyrocketed by 46.07% to -$9.9 million in 2023, then decreased by 2.77% to -$10.2 million in 2024, then skyrocketed by 67.24% to -$3.3 million in 2025.
  • Business Quant data shows Free Cash Flow for RPID at -$3.3 million in Q4 2025, -$9.7 million in Q3 2025, and -$9.5 million in Q2 2025.